# Adaptimmune Therapeutics PLC: Form 8-K, filed Sep 5, 2018

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 8-K
- Filed: 2018-09-05
- Accepted by EDGAR: Sep 5, 2018, 07:50 ET
- Period: 2018-09-05
- Accession: 0001104659-18-055198
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000110465918055198/a18-26035_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000110465918055198/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000110465918055198/a18-26035_18k.htm

Filed Sep 5, 2018.
Source: SEC EDGAR, the filing index for accession 0001104659-18-055198. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
